Skip to Content
Return to Navigation

Gilead Announces Long-Awaited Price For Covid-19 Drug Remdesivir-STAT, 6/29

Since remdesivir became the first medicine shown to have an impact on Covid-19, doctors, politicians, and Wall Street investors have engaged in a tense guessing game: What would its maker, Gilead Sciences, charge for the drug? Now there is an answer. STAT, 06/29/2020

Share this article: